Delivery Order SPE2DB22D2103-SPE2DB24FR8RR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,593.08 Firm Fixed Price delivery order supports the supply of LIVALO 1 MG TABLET 90S to the DLA. The contract has an ultimate completion date of December 27, 2024. No set-aside designation was used for this award. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.72, is a delivery order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,773.56 Firm Fixed Price Delivery Order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.41 Firm Fixed Price delivery order is for the supply of LIVALO 2 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.93 Firm Fixed Price Delivery Order covers the provision of LIVALO 1 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and was awarded on December 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FL6R2, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4562909046 LIVALO 1 MG TABLET 90S. The contract has a firm fixed price of $2,226.56 and a completion date of November 28, 2023. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, with ID SPE2DX15D3020|SPE2DX23FXHLN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,185.76 firm-fixed-price delivery order is for the supply of the pharmaceutical product LIVALO 2 MG TABLET 90S. The contract has an ultimate completion date of August 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF5CW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, a firm fixed price delivery order, is for the supply of 4564119207 LIVALO 2 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $4,226.89 and a period of performance through April 1, 2024....
- This federal contract award, valued at $2,540.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare...
- This federal contract award, with ID SPE2DB22D2103|SPE2DB24FR9MZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $42,257.63 firm-fixed-price delivery order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8RRDelivery Order
This federal contract award, with ID SPE2DB22D2103|SPE2DB24FR8RR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,803.18 firm fixed-price delivery order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2023. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.8k | 12/20/23 |